pentobarbital will reduce the extent or influence of bedaquiline by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Stay clear of or Use Alternate Drug. Steer clear of coadministration of bedaquiline with powerful CYP3A4 inducers on account of potential for lowered therapeutic outcomepentobarbital decreases results of sufentanil SL by infl